KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Amortization - Goodwill Cost of Revenue Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ginkgo Bioworks Holdings (DNA) Shares Issued (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Shares Issued readings, the most recent being $19.5 million for Q4 2025.

On a quarterly basis, Shares Issued rose 23077.38% to $19.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.5 million, a 23077.38% increase, with the full-year FY2025 number at $19.5 million, up 23077.38% from a year prior.
Shares Issued hit $19.5 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $84000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $19.5 million in Q4 2025 to a low of -$16.9 million in Q3 2022.
Median Shares Issued over the past 5 years was $27000.0 (2021), compared with a mean of $1.2 million.
Biggest five-year swings in Shares Issued: crashed 78426.32% in 2021 and later skyrocketed 141066.67% in 2022.
Ginkgo Bioworks Holdings' Shares Issued stood at -$14.9 million in 2021, then skyrocketed by 100.8% to $120000.0 in 2022, then plummeted by 88.33% to $14000.0 in 2023, then surged by 500.0% to $84000.0 in 2024, then skyrocketed by 23077.38% to $19.5 million in 2025.
The last three reported values for Shares Issued were $19.5 million (Q4 2025), $84000.0 (Q4 2024), and -$84000.0 (Q3 2024) per Business Quant data.